Lys Therapeutics products

Lys - Model Glunomab / Glunozumab - Monoclonal Antibody

Glunomab / Glunozumab®: a monoclonal antibody counteracting the strong toxicity triggered by the interaction of an endogenous protease, tissue plasminogen activator (tPA) with NMDA receptors (NMDAr)